South Korea Single Cell Analysis Market Size & Outlook
The single cell analysis market in South Korea is expected to reach a projected revenue of US$ 280.2 million by 2033. A compound annual growth rate of 22.59% is expected of South Korea single cell analysis market from 2026 to 2033.
In terms of revenue, South Korea accounted for 1.0% of the global single cell analysis market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China single cell analysis market is projected to lead the regional market in terms of revenue in 2033.
Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 870.5 million by 2033.
Over the past few years, the single-cell analysis market in South Korea has undergone several changes, leading to significant growth in the market. According to Front Line Genomics, in November 2023, genetic testing was commonly employed for hereditary diseases, especially in infants, and was extensively used after cancer diagnoses to guide precision medicine interventions.
South Korea utilizes advanced genomic research to pioneer innovative treatments, employing modern technology for genetic testing. The South Korean government has allocated approximately USD 55.7 million to develop these treatments.
According to Pharma Manufacturing, in June 2021, with a USD 1.7 billion investment, South Korea launched a 5-year plan in 2019 to advance research, development, and commercialization in medical biotechnology sectors.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Single Cell Analysis Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.03% in 2025.
Horizon Databook has segmented the South Korea single cell analysis market based on instruments, consumables covering the revenue growth of each sub-segment from 2021 to 2033.
Over the past few years, the single-cell analysis market in South Korea has undergone several changes, leading to significant growth in the market. According to Front Line Genomics, in November 2023, genetic testing was commonly employed for hereditary diseases, especially in infants, and was extensively used after cancer diagnoses to guide precision medicine interventions.
South Korea utilizes advanced genomic research to pioneer innovative treatments, employing modern technology for genetic testing. The South Korean government has allocated approximately USD 55.7 million to develop these treatments.
According to Pharma Manufacturing, in June 2021, with a USD 1.7 billion investment, South Korea launched a 5-year plan in 2019 to advance research, development, and commercialization in medical biotechnology sectors.
South Korea Single Cell Analysis Market Product Outlook (Revenue, USD Million , 2021-2033)
Consumables
Instruments
South Korea Single Cell Analysis Market Application Outlook (Revenue, USD Million , 2021-2033)
Cancer
Immunology
Neurology
Stem Cell
Non invasive prenatal diagnosis
In vitro Fertilisation
Other Application
South Korea Single Cell Analysis Market Workflow Outlook (Revenue, USD Million , 2021-2033)
Single Cell Isolation & Library Preparation
Downstream Analysis
Data Analysis
South Korea Single Cell Analysis Market End Use Outlook (Revenue, USD Million , 2021-2033)
Academic & Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Other End Use
Reasons to subscribe to Single Cell Analysis Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Single Cell Analysis Market Outlook databook
Our clientele includes a mix of Single Cell Analysis Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Single Cell Analysis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Korea Single Cell Analysis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Korea Single Cell Analysis Market, 2021-2033 (US$M)